Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules

Journal of Virology

Volumn 88, Issue 6, 2014, Pages 3298-3308

  May, Nathan A ^a,e   Wang, Qiuhong ^a,f   Balbo, Andrea ^b   Konrad, Sheryl L ^a   Buchli, Rico ^c   Hildebrand, William H ^d   Schuck, Peter ^b   Hudson, Amy W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c Pure Protein LLC   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e Laboratory of Immunology   (United States)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OLIGOMER; SOLUBLE U21 PROTEIN; TETRAMER; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 7; LYSOSOME; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; SEDIMENTATION RATE; STOICHIOMETRY; ULTRACENTRIFUGATION;

CARRIER PROTEINS; HERPESVIRUS 7, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; ROSEOLOVIRUS INFECTIONS; VIRAL PROTEINS;

EID: 84894543495     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02639-13     Document Type: Article

References (57)

1. Glosson NL, Hudson AW. 2007. Human herpesvirus-6A and-6B encode viral immunoevasins that downregulate class I MHC molecules. Virology 365:125-135. http://dx.doi.org/10.1016/j.virol.2007.03.048.
2. Hudson AW, Blom D, Howley PM, Ploegh HL. 2003. The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic 4:824-837. http://dx.doi.org/10.1046/j.1398-9219.2003.0137.x.
3. Hudson AW, Howley PM, Ploegh HL. 2001. A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J. Virol. 75:12347-12358. http://dx.doi.org/10.1128/JVI.75.24.12347-12358.2001.
4. Schneider CL, Hudson A. 2011. The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB. PLoS Pathog. 7:e1002362. http://dx.doi.org/10.1371/journal.ppat.1002362.
5. Glosson NL, Gonyo P, May NA, Schneider CL, Ristow LC, Wang Q, Hudson AW. 2010. Insight into the mechanism of human herpesvirus 7 U21-mediated diversion of class I MHC molecules to lysosomes. J. Biol. Chem. 285:37016-37029. http://dx.doi.org/10.1074/jbc.M110.125849.
6. May NA, Glosson NL, Hudson AW. 2010. HHV-7 U21 downregulates classical and nonclassical class I MHC molecules from the cell surface. J. Virol. 84:3738-3751. http://dx.doi.org/10.1128/JVI.01782-09.
7. Mostoslavsky G, Fabian AJ, Rooney S, Alt FW, Mulligan RC. 2006. Complete correction of murine Artemis immunodeficiency by lentiviral vectormediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 103:16406-16411. http://dx.doi.org/10.1073/pnas.0608130103.
8. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9-20. http://dx.doi.org/10.1016/0092-8674(78) 90296-9.
9. Stam NJ, Spits H, Ploegh HL. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137:2299-2306.
10. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. 2002. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111:967-979. http://dx.doi.org/10.1016/S0092-8674(02)01194-7.
11. Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH. 2004. Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. Biochemistry 43:14852-14863. http://dx.doi.org/10.1021/bi048580q.
12. Prilliman K, Lindsey M, Zuo Y, Jackson KW, Zhang Y, Hildebrand W. 1997. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics 45:379-385. http://dx.doi.org/10.1007/s002510050219.
13. Renart J, Reiser J, Stark GR. 1979. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc. Natl. Acad. Sci. U.S.A. 76:3116-3120. http://dx.doi.org/10.1073/pnas.76.7.3116.
14. Li Y, Wojcik R, Dovichi NJ, Champion MM. 2012. Quantitative multiple reaction monitoring of peptide abundance introduced via a capillary zone electrophoresis-electrospray interface. Anal. Chem. 84:6116-6121. http://dx.doi.org/10.1021/ac300926h.
15. Zhao H, Brautigam CA, Ghirlando R, Schuck P. 2013. Overview of current methods in sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation. Curr. Protoc. Protein Sci. Chapter 20:Unit20.12. http://dx.doi.org/10.1002/0471140864.ps2012s71.
16. Balbo A, Minor KH, Velikovsky CA, Mariuzza RA, Peterson CB, Schuck P. 2005. Studying multiprotein complexes by multisignal sedimentation velocity analytical ultracentrifugation. Proc. Natl. Acad. Sci. U.S.A. 102:81-86. http://dx.doi.org/10.1073/pnas.0408399102.
17. Cohn E, Edsall J. 1943. Density and apparent specific volume of proteins, p 370-381. In Cohn EJ, Edsall JT (ed), Proteins, amino acids, and peptides. Van Nostrand-Reinhold, Princeton, NJ.
18. Lewis MS, Junghans RP. 2000. Ultracentrifugal analysis of molecular mass of glycoproteins of unknown or ill-defined carbohydrate composition. Methods Enzymol. 321:136-149.
19. Schuck P. 2000. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78:1606-1619. http://dx.doi.org/10.1016/S0006-3495(00) 76713-0.
20. Schuck P, Demeler B. 1999. Direct sedimentation analysis of interference optical data in analytical ultracentrifugation. Biophys. J. 76:2288-2296. http://dx.doi.org/10.1016/S0006-3495(99)77384-4.
21. Zhao H, Ghirlando R, Piszczek G, Curth U, Brautigam CA, Schuck P. 2013. Recorded scan times can limit the accuracy of sedimentation coefficients in analytical ultracentrifugation. Anal. Biochem. 437:104-108. http://dx.doi.org/10.1016/j.ab.2013.02.011.
22. Brown PH, Balbo A, Schuck P. 2009. On the analysis of sedimentation velocity in the study of protein complexes. Eur. Biophys. J. 38:1079-1099. http://dx.doi.org/10.1007/s00249-009-0514-1.
23. Schuck P, Taraporewala Z, McPhie P, Patton JT. 2001. Rotavirus nonstructural protein NSP2 self-assembles into octamers that undergo ligandinduced conformational changes. J. Biol. Chem. 276:9679-9687. http://dx.doi.org/10.1074/jbc.M009398200.
24. Pace CN, Vajdos F, Fee L, Grimsley G, Gray T. 1995. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4:2411-2423. http://dx.doi.org/10.1002/pro.5560041120.
25. Zhao H, Brown PH, Schuck P. 2011. On the distribution of protein refractive index increments. Biophys. J. 100:2309-2317. http://dx.doi.org/10.1016/j.bpj.2011.03.004.
26. Padrick SB, Brautigam CA. 2011. Evaluating the stoichiometry of macromolecular complexes using multisignal sedimentation velocity. Methods 54:39-55. http://dx.doi.org/10.1016/j.ymeth.2011.01.002.
27. Vistica J, Dam J, Balbo A, Yikilmaz E, Mariuzza RA, Rouault TA, Schuck P. 2004. Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition. Anal. Biochem. 326:234-256. http://dx.doi.org/10.1016/j.ab.2003.12.014.
28. Kelley LA, Sternberg MJE. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protoc. 4:363-371. http://dx.doi.org/10.1038/nprot.2009.2.
29. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5:725-738. http://dx.doi.org/10.1038/nprot.2010.5.
30. Shi J, Blundell TL, Mizuguchi K. 2001. FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J. Mol. Biol. 310:243-257. http://dx.doi.org/10.1006/jmbi.2001.4762.
31. Källberg M, Wang H, Wang S, Peng J, Wang Z, Lu H, Xu J. 2012. Templatebased protein structure modeling using the RaptorX Web server. Nat. Protoc. 7:1511-1522. http://dx.doi.org/10.1038/nprot.2012.085.
32. Wu S, Zhang Y. 2007. LOMETS: a local meta-threading-server for protein structure prediction. Nucleic Acids Res. 35:3375-3382. http://dx.doi.org/10.1093/nar/gkm251.
33. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. 2005. Protein identification and analysis tools on the ExPASy server, p 571-607. In Walker JM (ed), The proteomics protocols handbook. Humana Press, New York, NY.
34. Dam J, Schuck P. 2004. Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles, vol 384, p 185-212. Elsevier, Amsterdam, Netherlands.
35. Padrick SB, Deka RK, Chuang JL, Wynn RM, Chuang DT, Norgard MV, Rosen MK, Brautigam CA. 2010. Determination of protein complex stoichiometry through multisignal sedimentation velocity experiments. Anal. Biochem. 407:89-103. http://dx.doi.org/10.1016/j.ab.2010.07.017.
36. Rasband WS. 1997-2012. Image J. National Institutes of Health, Bethesda, MD. http://imagej.nih.gov/ij/.
37. Revilleza MJ, Wang R, Mans J, Hong M, Natarajan K, Margulies DH. 2011. How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J. Biomed. Biotechnol. 2011:724607.
38. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-517. http://dx.doi.org/10.1038/386514a0.
39. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510-514. http://dx.doi.org/10.1038/386510a0.
40. Chapman TL, Bjorkman PJ. 1998. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 72:460-466.
41. Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, Bjorkman PJ. 1995. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3:583-590. http://dx.doi.org/10.1016/1074-7613(95)90129-9.
42. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326. http://dx.doi.org/10.1126/science.1070884.
43. Smith HRC, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. U.S.A. 99: 8826-8831. http://dx.doi.org/10.1073/pnas.092258599.
44. Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier LL. 2003. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197:1245-1253. http://dx.doi.org/10.1084/jem.20021973.
45. Arapović J, Lenac Rovis T, Reddy AB, Krmpotić A, Jonjić S. 2009. Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 downmodulates RAE-1epsilon in addition to MULT-1 and H60. Mol. Immunol. 47:114-122. http://dx.doi.org/10.1016/j.molimm.2009.02.010.
46. Lenac T, Budt M, Arapović J, Hasan M, Zimmermann A, Simic H, Krmpotić A, Messerle M, Ruzsics Z, Koszinowski UH, Hengel H, Jonjić S. 2006. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203:1843-1850. http://dx.doi.org/10.1084/jem.20060514.
47. Mintern JD, Klemm EJ, Wagner M, Paquet ME, Napier MD, Kim YM, Koszinowski UH, Ploegh HL. 2006. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus Fc receptor-1. J. Immunol. 177:8422-8431.
48. Loewendorf AI, Steinbrueck L, Peter C, Busche A, Benedict CA, Kay-Jackson PC. 2011. The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses. J. Virol. 85:5208-5212. http://dx.doi.org/10.1128/JVI.02178-10.
49. Mans J, Natarajan K, Balbo A, Schuck P, Eikel D, Hess S, Robinson H, Simic H, Jonjić S, Tiemessen CT, Margulies DH. 2007. Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153. J. Biol. Chem. 282: 35247-35258. http://dx.doi.org/10.1074/jbc.M706782200.
50. Zhi L, Mans J, Paskow MJ, Brown PH, Schuck P, Jonjić S, Natarajan K, Margulies DH. 2010. Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. Biochemistry 49:2443-2453. http://dx.doi.org/10.1021/bi902130j.
51. Krmpotić A, Busch DH, Bubić I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjić S. 2002. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 3:529-535. http://dx.doi.org/10.1038/ni799.
52. Höning S, Griffith J, Geuze HJ, Hunziker W. 1996. The tyrosine-based lysosomal targeting signal in lamp-1 mediates sorting into Golgi-derived clathrin-coated vesicles. EMBO J. 15:5230-5239.
53. Williams MA, Fukuda M. 1990. Accumulation of membrane glycoproteins in lysosomes requires a tyrosine residue at a particular position in the cytoplasmic tail. J. Cell Biol. 111:955-966. http://dx.doi.org/10.1083/jcb.111.3.955.
54. Höning S, Hunziker W. 1995. Cytoplasmic determinants involved in direct lysosomal sorting, endocytosis, and basolateral targeting of rat lgp120 (lamp-I) in MDCK cells. J. Cell Biol. 128:321-332. http://dx.doi.org/10.1083/jcb.128.3.321.
55. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH. 1999. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.EMBOJ. 18:1081-1091. http://dx.doi.org/10.1093/emboj/18.4.1081.
56. Reusch U, Bernhard O, Koszinowski U, Schu P. 2002. AP-1A and AP-3A lysosomal sorting functions. Traffic 3:752-761. http://dx.doi.org/10.1034/j.1600-0854.2002.31007.x.
57. Wolins N, Bosshart H, Küster H, Bonifacino JS. 1997. Aggregation as a determinant of protein fate in post-Golgi compartments: role of the luminal domain of furin in lysosomal targeting. J. Cell Biol. 139:1735-1745. http://dx.doi.org/10.1083/jcb.139.7.1735.